Vilon

Bioregulator

ClassKhavinson dipeptide

Typical routes in papersOral / mucosal in that tradition

Half-life contextShort

EvidenceRussian bioregulator literature

What it is

Vilon (Lys-Glu) is a short thymic bioregulator in the Khavinson catalog, aimed at immune-aging conversations.

Benefits in plain language

What researchers and reference users usually mean when they talk about this compound. These are study themes and common claims — not a promise that it will do this in you.

Traditional claimed benefit: steadier immune tone in older adults.
Filed with Thymalin / thymogen rather than with BPC.
Western RCT support is thin.

If a branded, FDA-approved product exists, that label is the only dose that is actually authorized. Research-chemical vials are a different object.

Mechanism of action

Proposed gene-expression modulation in lymphoid tissue; mechanistic detail is sparse by modern receptor-drug standards.

Possible side effects / caveats

Under-characterized in Western pharm-tox. Vendor quality is the everyday risk.

Protocol ranges

Source tier	Amount	Frequency / duration	Notes
Cited bioregulator courses	1–2 mg class oral	Short courses of 10–20 days	Tradition, not a label

Numbers below and above are literature or community pointers, not a treatment plan. Approved products, when they exist, follow the official label — not a research vial.